Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term Follow-up Study of Efficacy and Immunogenicity of GEN-003 in Subjects With Genital Herpes Simplex Virus Type 2 (HSV-2) Infection

NCT02910284 is registered in ClinicalTrials.gov with Genocea Biosciences, Inc. as lead sponsor.

NCT NCT02910284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02910284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term Follow-up Study of Efficacy and Immunogenicity of GEN-003 in Subjects With Genital Herpes Simplex Virus Type 2 (HSV-2) Infection
Lead sponsor
Genocea Biosciences, Inc.
Phase
Observational
Overall status
Completed
Start date
September 16, 2016
Completion date
July 14, 2017
Enrollment
140 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

genital herpes simplex type 2